An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.
The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.
References
Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).
Recent Posts
Protect Audiology Licensure in Utah
The Utah Office of Professional Licensure Review (OPLR) has recommended a drastic change that would eliminate professional licensure for audiologists and speech-language pathologists and replace…
Government Re-Opening: What It Means for Hearing Health
After weeks of uncertainty, Congress has reached an agreement and is expected to vote later today on a continuing resolution to reopen the federal government…
Submit Your Poster Now
Join us in curating an annual convention program that amplifies the value of the profession. The AAA 2026 Program Committee is proud to invite clinicians,…


